​
​

Protara Therapeutics (TARA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Protara Therapeutics Revenue Highlights

00

Protara Therapeutics Revenue by Period

Protara Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--100.00%
2014-12-31$2.95M-

Protara Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Protara Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.21M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31--

Protara Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Protara Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VACCBarinthus Biotherapeutics$44.70M-
SQZSQZ Bio$21.03M-
IKNAIkena Oncology$9.16M-
LYRALyra Therapeutics$1.56M$195.00K
VCNXVaccinex$570.00K$52.00K
MGTADianthus Therapeutics$314.00K$72.00K
TARAProtara Therapeutics--
MTCRMetacrine--
TRVITrevi Therapeutics--
MNPRMonopar Therapeutics--
SRZNSurrozen--
SRRKScholar Rock--
XLOXilio Therapeutics-$2.36M

TARA Revenue FAQ

What is Protara Therapeutics’s yearly revenue?

Protara Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TARA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Protara Therapeutics’s quarterly revenue?

Protara Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TARA's quarterly revenue for Q4 2023 was $1.21M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Protara Therapeutics’s revenue growth rate?

Protara Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.